N1-Methyl-lysergic acid diethylamide
N1-Methyl-lysergic acid diethylamide
N1-Methyl-lysergic acid diethylamide (MLD-41) is a chemical compound that belongs to the ergoline family. It is a derivative of lysergic acid diethylamide (LSD), which is a well-known psychedelic drug. MLD-41 is characterized by the addition of a methyl group at the N1 position of the lysergic acid moiety.
Chemical Structure
MLD-41 shares a similar core structure with LSD, which is based on the ergoline skeleton. The primary difference between MLD-41 and LSD is the presence of a methyl group attached to the nitrogen atom at the N1 position. This modification can influence the compound's pharmacological properties and its interaction with serotonin receptors.
Pharmacology
MLD-41, like other ergoline derivatives, is believed to interact with various neurotransmitter systems in the brain, particularly the serotonin system. The addition of the methyl group may alter its binding affinity and efficacy at serotonin receptors, potentially leading to differences in its psychoactive effects compared to LSD.
Effects
The psychoactive effects of MLD-41 are not as well-documented as those of LSD. However, it is hypothesized that MLD-41 may produce similar hallucinogenic effects, including alterations in perception, mood, and cognition. The specific effects and potency of MLD-41 relative to LSD remain a subject of research.
Synthesis
The synthesis of MLD-41 involves the chemical modification of LSD. This process typically requires the introduction of a methyl group to the N1 position of the lysergic acid diethylamide molecule. The synthesis of such compounds is complex and requires expertise in organic chemistry.
Legal Status
The legal status of MLD-41 varies by country. In many jurisdictions, it may be classified under the same legal framework as LSD due to its structural similarity and potential for psychoactive effects. Researchers and chemists must be aware of the legal implications of working with such compounds.
Related Compounds
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD